Page Content
For Immediate Release:
May 6, 2020
Office of The Attorney General
Gurbir S. Grewal,
Attorney General
Division of Consumer Affairs
Paul R. Rodríguez,
Acting Director
|
For Further Information Contact:
Lisa Coryell 609-292-4791
|
Proposed Regulation – State Board of Medical ExaminersP
NEWARK – To address the ongoing opioid overdose epidemic and further increase the public availability of naloxone, the State Board of Medical Examiners (“the Board”) proposes to amend N.J.A.C. 13:35-7.6 to require prescribers to co-prescribe an opioid antidote (for example, naloxone) under certain circumstances. In addition, the Board proposes to amend N.J.A.C. 13:35-7.6 to implement P.L. 2017, c. 341 to clarify the timing of the requirement to enter into a pain management agreement, amend the definition of “initial prescription,” and revise the definition of “chronic pain” in the rule consistent with the amended statute.
The proposed regulation, and information on how to submit a comment by June 5, 2020, can be viewed on the Division of Consumer Affairs website
### |
Last Modified: 5/7/2020 6:12 AM
